CC-90003 is an irreversible and selective inhibitor of ERK 1/2 with antitumor activity.
CC-90003 is an irreversible and selective inhibitor of ERK 1/2 with antitumor activity[1].
[1]. Monica M. Mita, et al. A phase Ia study of CC-90003, a selective extracellular signal-regulated kinase (ERK) inhibitor, in patients with relapsed or refractory BRAF or RAS-mutant tumors. Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 2577-2577.
















